Gabapentina para el dolor neuropático crónico y la fibromialgia en adultos
Información
- DOI:
- https://doi.org/10.1002/14651858.CD007938.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 16 marzo 2011see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Dolor y cuidados paliativos
- Copyright:
-
- Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
PW registered the title. PW, RAM, and SD wrote the protocol.
PW, SD, and RAM assessed inclusion of papers and extracted data.
RAM wrote up the review. All authors contributed to the final draft and approved the published version.
PW will be responsible for the update.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
NHS Cochrane Collaboration Programme Grant Scheme, UK.
-
European Union Biomed 2 Grant no. BMH4 CT95 0172, UK.
Declarations of interest
SD, RAM and HJM have received research support from charities, government and industry sources at various times. RAM and HJM have consulted for various pharmaceutical companies. RAM and HJM have received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions. PW is a full‐time employee of the UK Cochrane Centre, funded by the UK National Institute of Health Research.
None of the authors have received any funds from any company with an interest in gabapentin for research on gabapentin, and none from any source for the production of this review. HJM at one time was paid by Pfizer to act on a Data Safety and Monitoring board (DSMB) for pregabalin trials (since abandoned).
Acknowledgements
We wish to thank Dr Thomas Perry for directing us to clinical trial reports and synopses of published and unpublished studies of gabapentin, and Dr Mike Clarke and colleagues for their advice and support.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Jun 09 | Gabapentin for chronic neuropathic pain in adults | Review | Philip J Wiffen, Sheena Derry, Rae Frances Bell, Andrew SC Rice, Thomas Rudolf Tölle, Tudor Phillips, R Andrew Moore | |
| 2014 Apr 27 | Gabapentin for chronic neuropathic pain and fibromyalgia in adults | Review | R Andrew Moore, Philip J Wiffen, Sheena Derry, Andrew SC Rice | |
| 2011 Mar 16 | Gabapentin for chronic neuropathic pain and fibromyalgia in adults | Review | R Andrew Moore, Philip J Wiffen, Sheena Derry, Henry J McQuay | |
| 2009 Jul 08 | Gabapentin for chronic neuropathic pain in adults | Protocol | R Andrew Moore, Philip J Wiffen, Sheena Derry, Henry J McQuay | |
Differences between protocol and review
The protocol for the original gabapentin review (Wiffen 2005) was superceded and split, and an updated protocol produced for this review, to reflect, at least in part, the more recent developments in understanding of potential biases in chronic pain trials, and new outcomes of direct relevance to patients. The main difference between the original review and the updated protocol for this review, was more emphasis being given to a set of core outcomes, although all of those outcomes were included in the updated protocol.
